Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis

Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis

<strong>Importance:</strong> Low-density lipoprotein cholesterol (LDL-C)–lowering alleles in or near NPC1L1 or HMGCR, encoding the respective molecular targets of ezetimibe and statins, have previously been used as proxies to study the efficacy of these lipid-lowering drugs. Alleles nea...

Full description

Bibliographic Details
Main Authors:	Lotta, L, Sharp, S, Burgess, S, Key, T, McCarthy, M, Et al.
Format:	Journal article
Published:	American Medical Association 2016

Similar Items

Association of genetically enhanced lipoprotein lipase-mediated lipolysis and low-density lipoprotein cholesterol-lowering alleles with risk of coronary disease and type 2 diabetes
by: Lotta, L, et al.
Published: (2018)

Association of genetically enhanced lipoprotein lipase–mediated lipolysis and low-density lipoprotein cholesterol–lowering alleles with risk of coronary disease and type 2 diabetes
by: Lotta, LA, et al.
Published: (2018)

Rare protein-truncating variants in APOB, lower low-density lipoprotein cholesterol, and protection against coronary heart disease
by: Peloso, G, et al.
Published: (2019)

Peningkatan rasio Low Density Lipoprotein Cholesterol dengan High Density Lipoprotein Cholesterol sebagai faktor resiko stroke iskemik
by: , ARITYAWAN, Fred Septo, et al.
Published: (2007)

Factors associated with nonachievement of low density lipoprotein cholesterol target among patients with type 2 diabetes mellitus
by: Mat Yudin, Zainab
Published: (2015)

Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9
by: Schmidt, A, et al.
Published: (2019)

Identifying susceptibility variants for type 2 diabetes.
by: Zeggini, E, et al.
Published: (2007)

Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
by: Colquhoun, D, et al.
Published: (2004)

The genetics of type 2 diabetes.
by: Gloyn, A, et al.
Published: (2001)

Genetics of type 2 diabetes.
by: Owen, K, et al.
Published: (2007)

Genetics of type 2 diabetes.
by: McCarthy, M, et al.
Published: (2006)

Genetically-predicted effects of LDL cholesterol lowering therapeutic targets on the risk of diabetes
by: Lind, K
Published: (2022)

The importance of context: uncovering species- and tissue-specific effects of genetic risk variants for type 2 diabetes
by: Thomsen, S, et al.
Published: (2016)

Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases?
by: Nakamura, K, et al.
Published: (2009)

A common KIF6 polymorphism increases vulnerability to low-density lipoprotein cholesterol: Two meta-analyses and a meta-regression analysis
by: Ference, B, et al.
Published: (2011)

The importance of global studies of the genetics of type 2 diabetes.
by: McCarthy, M
Published: (2011)

Control of blood pressure and low-density lipoprotein cholesterol with single-pill amlodipine/atorvastatin: a pooled analysis of patients with and without diabetes
by: Jenssen, T, et al.
Published: (2008)

Apo B genetic variants that modulate postprandial lipoprotein metabolism
by: Talmud, P, et al.
Published: (1996)

Genetic Variants in Lp(a) Lipoprotein and Coronary Disease REPLY
by: Farrall, M, et al.
Published: (2010)

Phenotypic characterization of genetically lowered human lipoprotein(a) levels
by: Emdin, C, et al.
Published: (2016)

The genetics of type 2 diabetes and its clinical relevance.
by: Pal, A, et al.
Published: (2013)

Genetics: how the UKPDS contributed to determining the genetic landscape of Type 2 diabetes.
by: Gloyn, A, et al.
Published: (2008)

Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.
by: Niu, Y, et al.
Published: (2008)

Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity
by: Scott, R, et al.
Published: (2014)

Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity.
by: Scott, R, et al.
Published: (2014)

Recent Developments in the Genetic and Genomic Basis of Type 2 Diabetes
by: Richards, H, et al.
Published: (2013)

The genetic and epigenetic basis of type 2 diabetes and obesity.
by: Drong, A, et al.
Published: (2012)

The genetic and epigenetic basis of type 2 diabetes and obesity
by: Drong, A, et al.
Published: (2012)

Discovery of novel genes for serum urate and low-density lipoprotein cholesterol - Two biomarkers of cardiovascular disease
by: Wallace, C, et al.
Published: (2007)

Konsentrasi rendah high density lipoprotein-cholesterol (HDL-C) sebagai faktor resiko stroke infark
by: , LUBIS, Irsan, et al.
Published: (1999)

Konsentrasi tinggi Low Density Lipoprotein-Cholesterol (LDL-C) sebagai faktor risiko demensia vaskuler
by: , SUNARYO, et al.
Published: (2006)

The genetics of type 2 diabetes.
by: Mccarthy, M, et al.
Published: (2001)

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
by: Clarke, R, et al.
Published: (2009)

Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk.
by: Lango, H, et al.
Published: (2008)

Genetics of type 2 diabetes mellitus and obesity--a review.
by: Jafar-Mohammadi, B, et al.
Published: (2008)

Prioritising risk factors for type 2 diabetes: causal inference through genetic approaches
by: Wittemans, L, et al.
Published: (2018)

FTO genetic variants and risk of obesity and type 2 diabetes: a meta-analysis of 28,394 Indians.
by: Vasan, S, et al.
Published: (2014)

FTO genetic variants and risk of obesity and type 2 diabetes: A meta-analysis of 28,394 Indians
by: Vasan, S, et al.
Published: (2014)

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.
by: Kearney, P, et al.
Published: (2008)

Mechanisms of disease: genetic insights into the etiology of type 2 diabetes and obesity.
by: Lindgren, C, et al.
Published: (2008)